Skip to content

Author

Jeong-Gyu Choi

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

TL1A inhibitors in inflammatory bowel disease: A systematic review of phase 2 clinical trials

Background: Tumor necrosis factor-like ligand 1A (TL1A) (TNFSF15) signals through DR3 to drive both mucosal inflammation and intestinal fibrosis. Three anti-TL1A antibodies (tulisokibart, afimkibart, and duvakitug) have completed Phase 2 trials in inflammatory bowel disease (IBD). We performed a systematic review (SR)...

Jeong-Gyu Choi, E. Gong, Chang Seok Bang et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.